A device and method of using the device to detect the presence and composition of clots and other target objects in a circulatory vessel of a living subject is described. In particular, devices and methods of detecting the presence and composition of clots and other target objects in a circulatory vessel of a living subject using in vivo photoacoustic flow cytometry techniques is described.
New opportunity to accelerate innovative technologies
Learn more about the BioVentures Development Award program, a new funding mechanism designed to accelerate the pace of development of highly innovative technologies and entrepreneurship activity.
ARHVA's Funding Opportunity
AR Health Ventures Accelerator (ARHVA) is seeking innovative proposals for therapeutic development. The program aims to accelerate scientific discoveries into practical therapies, bridging the gap between research and commercialization. Open to all UAMS employees. Deadline: September 29, 2023.
Provided herein are compounds, comprising Formula (I) or Formula (II), and their pharmaceutically acceptable salts. Also provided are pharmaceutical compositions comprising a pharmaceutically acceptable excipient and at least one compound of Formula (I) and (II), singly or in combination with other pharmaceutically active ingredients, such as anti-inflammatory agents or anticancer agents.
BioVentures was established as a formal outgrowth of the University of Arkansas for Medical Sciences‘ (UAMS) interest in promoting a biomedical technology industry for Arkansas and translating its research into products that benefit human health.
UAMS established BioVentures to maximize global, industrial interaction with the University of Arkansas faculty, as well as to facilitate technology transfer, the development of startup companies that are based on technology developed at UAMS, and contributions to Arkansas’ economic development.
BioVentures links the research minds at UAMS to global markets in order to advance Arkansas’ scientific and economic development.
Submit your proposals for the AR Health Ventures Accelerator program by September 29th. Apply now!
BioVentures is excited to announce an enlightening talk by our Program Manager, Dr. Stefanie Kennon-McGill, as part of the TRI Research Fundamentals Seminar Series. Dr.
BioVentures strengthens strategic direction at AUTM 2023, bolstering industry connections and insights to propel technology transfer endeavors.